Lisa A. King

2.3k total citations
27 papers, 714 citations indexed

About

Lisa A. King is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Lisa A. King has authored 27 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Lisa A. King's work include CAR-T cell therapy research (10 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (6 papers). Lisa A. King is often cited by papers focused on CAR-T cell therapy research (10 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (6 papers). Lisa A. King collaborates with scholars based in Netherlands, France and United States. Lisa A. King's co-authors include Hans van Vliet, Tanja D. de Gruijl, Paul W.H.I. Parren, Sandra Smole, Robert D. Arbeit, Henriette de Valk, Peter Leopold, V. Goulet, M.Linette Casey and Martine Wallon and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Immunology and American Journal of Epidemiology.

In The Last Decade

Lisa A. King

27 papers receiving 695 citations

Peers

Lisa A. King
Angela Cannas Italy
Salina Torres United States
Christina Megli United States
J.-C. Lin Taiwan
M. H. A. Hermans Netherlands
Pablo A. Romagnoli United States
Pär Larsson Sweden
Maria Angela Biasolo Italy
Mara G. Shainheit United States
Thorsten Thye Germany
Angela Cannas Italy
Lisa A. King
Citations per year, relative to Lisa A. King Lisa A. King (= 1×) peers Angela Cannas

Countries citing papers authored by Lisa A. King

Since Specialization
Citations

This map shows the geographic impact of Lisa A. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa A. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa A. King more than expected).

Fields of papers citing papers by Lisa A. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa A. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa A. King. The network helps show where Lisa A. King may publish in the future.

Co-authorship network of co-authors of Lisa A. King

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa A. King. A scholar is included among the top collaborators of Lisa A. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa A. King. Lisa A. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
King, Lisa A., Małgorzata Roos, George L. Scheffer, et al.. (2025). PD-L1 directed bispecific Vδ2-T cell engager combines lysis of PD-L1 expressing tumor cells with PD-1 immune checkpoint inhibition and modulation of the tumor immune microenvironment. Journal for ImmunoTherapy of Cancer. 13(10). e012255–e012255. 1 indexed citations
2.
King, Lisa A., Iris C. Blijdorp, André N. Vis, et al.. (2024). Leveraging Vγ9Vδ2 T cells against prostate cancer through a VHH-based PSMA-Vδ2 bispecific T cell engager. iScience. 27(12). 111289–111289. 1 indexed citations
3.
King, Lisa A., et al.. (2024). Vδ2 T-cell engagers bivalent for Vδ2-TCR binding provide anti-tumor immunity and support robust Vγ9Vδ2 T-cell expansion. Frontiers in Oncology. 14. 1474007–1474007. 1 indexed citations
4.
Jorritsma, Tineke, et al.. (2024). Isolation and expansion of pure and functional γδ T cells. Frontiers in Immunology. 15. 1336870–1336870. 4 indexed citations
5.
King, Lisa A., Manon C. Slot, Derk Amsen, et al.. (2023). A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors. Cancer Immunology Research. 11(9). 1237–1252. 21 indexed citations
6.
Bresser, Kaspar, Lianne Kok, Lisa A. King, et al.. (2022). Replicative history marks transcriptional and functional disparity in the CD8+ T cell memory pool. Nature Immunology. 23(5). 791–801. 29 indexed citations
7.
King, Lisa A., et al.. (2022). Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future. Frontiers in Immunology. 13. 915837–915837. 115 indexed citations
8.
Sheikhi, Abdolkarim, Roeland Lameris, Lisa A. King, et al.. (2021). Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor. Cancers. 13(21). 5446–5446. 17 indexed citations
9.
King, Lisa A., Roeland Lameris, Tanja D. de Gruijl, & Hans van Vliet. (2018). CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond. Frontiers in Immunology. 9. 1519–1519. 24 indexed citations
10.
Bruyand, Mathias, Patricia Mariani‐Kurkdjian, Malika Gouali, et al.. (2017). Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection. Médecine et Maladies Infectieuses. 48(3). 167–174. 80 indexed citations
11.
Cauteren, Dieter Van, Henriette de Valk, Cécile Sommen, et al.. (2015). Community Incidence of Campylobacteriosis and Nontyphoidal Salmonellosis, France, 2008–2013. Foodborne Pathogens and Disease. 12(8). 664–669. 25 indexed citations
12.
Werber, Dirk, Lisa A. King, Luise Müller, et al.. (2013). Associations of Age and Sex With the Clinical Outcome and Incubation Period of Shiga toxin-producing Escherichia coli O104:H4 Infections, 2011. American Journal of Epidemiology. 178(6). 984–992. 17 indexed citations
13.
Valk, Henriette de, Nathalie Jourdan‐Da Silva, Lisa A. King, et al.. (2012). Les infections d’origine alimentaire en France. Bulletin de l Académie Nationale de Médecine. 196(8). 1645–1657. 1 indexed citations
14.
King, Lisa A., Hervé Tissot‐Dupont, Christine Giraud, et al.. (2011). Outbreak of Q fever, Florac, Southern France, Spring 2007. Vector-Borne and Zoonotic Diseases. 11(4). 341–347. 12 indexed citations
15.
Bertholet‐Thomas, Aurélia, Bruno Ranchin, Lisa A. King, et al.. (2011). Syndrome hémolytique et urémique post-diarrhéique : Quand y penser ? Quel suivi ?. Archives de Pédiatrie. 18(7). 823–830. 8 indexed citations
16.
King, Lisa A., Taina Niskanen, Miia Lindström, et al.. (2009). Botulism and hot-smoked whitefish: a family cluster of type E botulism in France, September 2009. Eurosurveillance. 14(45). 17 indexed citations
17.
Smole, Sandra, Lisa A. King, Peter Leopold, & Robert D. Arbeit. (2002). Sample preparation of Gram-positive bacteria for identification by matrix assisted laser desorption/ionization time-of-flight. Journal of Microbiological Methods. 48(2-3). 107–115. 62 indexed citations
18.
King, Lisa A. & Bruce R. Carr. (1999). Phytoestrogens: Fact and fiction. 33(6). 127–143. 3 indexed citations
19.
Rowe, Thomas, Lisa A. King, Paul C. MacDonald, & M.Linette Casey. (1997). Tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 expression in human amnion mesenchymal and epithelial cells. American Journal of Obstetrics and Gynecology. 176(4). 915–921. 40 indexed citations
20.
King, Lisa A., Paul C. MacDonald, & M.Linette Casey. (1997). Regulation of metallothionein expression in human amnion epithelial and mesenchymal cells. American Journal of Obstetrics and Gynecology. 177(6). 1496–1501. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Cannas Breakdown of academic impact, for papers by Salina Torres Breakdown of academic impact, for papers by Christina Megli Breakdown of academic impact, for papers by J.-C. Lin Breakdown of academic impact, for papers by M. H. A. Hermans Breakdown of academic impact, for papers by Pablo A. Romagnoli Breakdown of academic impact, for papers by Pär Larsson Breakdown of academic impact, for papers by Maria Angela Biasolo Breakdown of academic impact, for papers by Mara G. Shainheit Breakdown of academic impact, for papers by Thorsten Thye
Rankless by CCL
2026